Ling Xin

Design, waterproofing, and mass production of the 3-inch PMT frontend system of JUNO

Jilei Xu, C. Cerna, Thomas Adam, Shakeel Ahmad et autres

fr (code pays fourni par la source)

[More than 130 years of breast cancer surgery and clinical practice in China].

Y H Liu, Ling Xin, Yuxuan Song

. Additionally,the guidelines recommend axillary lymph node dissection can be omitted in patients with negative sentinel lymph nodes,supported by high-level evidence. The AJCC Cancer Staging System (8th Edition) showed the evaluation of breast cancer burden has transcended TNM stage,leading to the level …

cn (code pays fourni par la source)

HER2-targeted PET/CT imaging provides potential biomarkers for differentiating HER2-zero, -low, and -positive breast cancer

Yuan Gao, Lei Yin, Xiaojiang Duan, Zhijian Fu et autres

cn (code pays fourni par la source)

Abstract 2945: PLB-002 is a novel Claudin 6 antibody-drug conjugate for ovarian cancer and testicular germ cell cancer

Hai‐Tao Pan, Qing Zhang, Ganyuan Xiao, Guangchao Zhang et autres

Abstract Background: Claudin 6 (CLDN6) is a clinically validated target for many solid tumors notably ovarian, endometrial, and testicular cancer. Its expression is restricted to tumor cells and fetal tissues with little or no detectable in normal tissues. As such, CLDN6 represents …

us (code pays fourni par la source)

[Quality Control Indexes for Oncology (2023 edition) and hot topics in breast surgery].

Ling Xin, Hongyu Xiang, J M Ye, Y H Liu

, and presented recommendations for the hot topics of breast surgery, such as pathological sampling of the breast specimen, sentinel lymph node biopsy for early-stage breast cancer, breast conserving surgery, axillary lymph node dissection, breast reconstruction surgery, endoscopic-assisted breast surgery, the principles …

cn (code pays fourni par la source)

A multicenter study of the clinicopathological characteristics and a risk prediction model of early-stage breast cancer with hormone receptor-positive/human epidermal growth factor receptor 2-low expression

Ling Xin, Qian Wu, Chongming Zhan, Hongyan Qin et autres

BACKGROUND: In light of the significant clinical benefits of antibody-drug conjugates in clinical trials, the human epidermal growth factor receptor 2 (HER2)-low category in breast cancers has gained increasing attention. Therefore, we studied the clinicopathological characteristics of Chinese patients with hormone receptor …

cn, jp (code pays fourni par la source)

Lateral Intraventricular Epidermoid Cyst

Zhe Cheng, Yu Sun, Yuan Hu, Ling Xin et autres

Epidermoid cysts originate from ectopic embryonic epithelial cells and are a very common type of benign intracranial tumor. However, the incidence of intraventricular epidermoid cysts is low, and lateral intraventricular epidermoid cysts are even rarer. Here, we present a case of lateral …

cn (code pays fourni par la source)

A comparison between a clinical decision support system and clinicians with guidelines in breast cancer.

Jianbin Li, Yang Yuan, Li Bian, Hua Yang et autres

e13551 Background: We are building a clinical decision support system (CSCO AI) for breast cancer patients to improve the efficiency of clinical decision-making. We aimed to assess cancer treatment regimens, in neoadjuvant therapy, adjuvant chemotherapy, adjuvant endocrine therapy, first line therapy and …

cn (code pays fourni par la source)

Correlation between Androgen Receptor Expression in Luminal B (HER–2 Negative) Breast Cancer and Disease Outcomes

Fan Yang, Jiayi Li, Hong Zhang, Shuang Zhang et autres

(1) Background: Hormone receptor positive breast cancer is a subtype of breast cancer with relatively good prognosis, but luminal B (HER−2 negative) breast cancer has a higher risk of recurrence and metastasis. Patients with endocrine therapy resistance and chemotherapy insensitivity have poor …

cn (code pays fourni par la source)

Androgen Receptor: A New Marker to Predict Pathological Complete Response in HER2-Positive Breast Cancer Patients Treated with Trastuzumab Plus Pertuzumab Neoadjuvant Therapy

Jiayi Li, Shuang Zhang, Chen Ye, Qian Liu et autres

(1) Background: Neoadjuvant therapy is the main therapeutic strategy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer patients, and the combination of trastuzumab and pertuzumab (HP) has become a routine treatment. How to predict and screen patients who are less …

cn (code pays fourni par la source)

A Comparison Between CSCO AI and Clinicians in Breast Cancer: A Double-Blind, Controlled Phase III Trial

Jianbin Li, Yang Yuan, Li Bian, Qiang Lin et autres

cn (code pays fourni par la source)

A Clinical–Radiomics Model for Predicting Axillary Pathologic Complete Response in Breast Cancer With Axillary Lymph Node Metastases

Liangyu Gan, Mingming Ma, Yinhua Liu, Qian Liu et autres

PURPOSE: To develop a clinical-radiomics model based on radiomics features extracted from MRI and clinicopathologic factors for predicting the axillary pathologic complete response (apCR) in breast cancer (BC) patients with axillary lymph node (ALN) metastases. MATERIALS AND METHODS: The MR images and …

cn (code pays fourni par la source)